Pages that link to "Q33396437"

The following pages link to Immunoglobulin prophylaxis in hematopoietic stem cell transplantation: systematic review and meta-analysis (Q33396437):

Displaying 43 items.

• Cytomegalovirus: pathogen, paradigm, and puzzle (Q33351523) (← links)
• Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europe (Q33419638) (← links)
• Human cytomegalovirus Fcγ binding proteins gp34 and gp68 antagonize Fcγ receptors I, II and III (Q33618817) (← links)
• Longitudinal Analysis of Tetanus- and Influenza-Specific IgG Antibodies in Myeloma Patients (Q35846308) (← links)
• Intravenous immune globulin and thromboembolic adverse events: A systematic review and meta-analysis of RCTs (Q35955607) (← links)
• Protocol for updating a systematic review of randomised controlled trials on the prophylactic use of intravenous immunoglobulin for patients undergoing haematopoietic stem cell transplantation (Q35999034) (← links)
• Management of respiratory viral infections in hematopoietic cell transplant recipients (Q36439896) (← links)
• Plasma markers of B-cell activation and clonality in pediatric liver and hematopoietic stem cell transplant recipients (Q36592302) (← links)
• Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group Report (Q36783762) (← links)
• Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016. (Q37150434) (← links)
• Cytomegalovirus pneumonia in hematopoietic stem cell recipients. (Q37179131) (← links)
• Prophylaxis regimens for GVHD: systematic review and meta-analysis (Q37322076) (← links)
• Cytomegalovirus and varicella-zoster virus vaccines in hematopoietic stem cell transplantation (Q37559627) (← links)
• Cytomegalovirus infection/disease after hematopoietic stem cell transplantation (Q37736316) (← links)
• Polyclonal Immunoglobulins and Hyperimmune Globulins in Prevention and Management of Infectious Diseases (Q37952919) (← links)
• Complications, Diagnosis, Management, and Prevention of CMV Infections: Current and Future (Q37967291) (← links)
• Human cytomegalovirus infection and atherothrombosis (Q37967568) (← links)
• Intravenous Immunoglobulin (IVIg) for Refractory and Difficult-to-treat Infections (Q38011449) (← links)
• Therapeutic strategies for the prevention and treatment of cytomegalovirus infection (Q38014916) (← links)
• Clinical applications of immunoglobulin: update (Q38050751) (← links)
• CMV-encoded Fcγ receptors: modulators at the interface of innate and adaptive immunity (Q38257496) (← links)
• National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report (Q38405199) (← links)
• Therapeutic strategies for cytomegalovirus in allogeneic hematopoietic cell transplantation (Q38617612) (← links)
• A national survey of screening and management of hypogammaglobulinemia in Canadian transplantation centers (Q38830258) (← links)
• Antiviral function and efficacy of polyvalent immunoglobulin products against CMV isolates in different human cell lines (Q39403005) (← links)
• Comparison of prophylactic use of intravenous immunoglobulin versus Pentaglobin® in pediatric patients after hematopoietic stem cell transplantation (Q40129026) (← links)
• The role of immunoglobulin prophylaxis for prevention of cytomegalovirus infection in pediatric hematopoietic stem cell transplantation recipients (Q40372039) (← links)
• Immunoglobulin Prophylaxis Against Cytomegalovirus Infection in Patients at High Risk of Infection Following Allogeneic Hematopoietic Cell Transplantation (Q42628858) (← links)
• A single-center experience of cytomegalovirus infections in Asian pediatric patients undergoing allogeneic hematopoietic stem cell transplant for leukemia in Singapore (Q45764693) (← links)
• Comparison of Weight-Based Dosing Strategies for Intravenous Immunoglobulin in Patients with Hematologic Malignancies (Q47182455) (← links)
• Epidemiology and risk factors of invasive fungal infections in a large cohort of patients with chronic lymphocytic leukemia. (Q48349084) (← links)
• Clinical indications for intravenous immunoglobulin utilization in a tertiary medical center: a 9-year retrospective study (Q49381645) (← links)
• Optimal donor for severe aplastic anemia patient requiring allogeneic hematopoietic stem cell transplantation: A large-sample study from China (Q50057440) (← links)
• Prophylactic intravenous immunoglobulin during autologous haemopoietic stem cell transplantation for multiple myeloma is not associated with reduced infectious complications. (Q53240561) (← links)
• Cytotect®CP as salvage therapy in patients with CMV infection following allogeneic hematopoietic cell transplantation: a multicenter retrospective study. (Q53695594) (← links)
• Prevalence and Safety of Intravenous Immunoglobulin Administration During Maintenance Chemotherapy in Children with Acute Lymphoblastic Leukemia in First Complete Remission: A Health Maintenance Organization Perspective. (Q55437757) (← links)
• European consensus proposal for immunoglobulin therapies (Q60699516) (← links)
• Retrospective analysis of weekly intravenous immunoglobulin prophylaxis versus intravenous immunoglobulin by IgG level monitoring in hematopoietic stem cell transplant recipients (Q82494163) (← links)
• Long-term outcome of HLA-haploidentical hematopoietic SCT without in vitro T-cell depletion for adult severe aplastic anemia after modified conditioning and supportive therapy (Q87165752) (← links)
• CMV Management with Specific Immunoglobulins: A Multicentric Retrospective Analysis on 92 Allotransplanted Patients (Q90136869) (← links)
• Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7) (Q92462748) (← links)
• Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients (Q92700078) (← links)
• Identification and Functional Characterization of a Novel Fc Gamma-Binding Glycoprotein in Rhesus Cytomegalovirus (Q93380481) (← links)